<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The predictive value (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>) and association of 4 <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> with clinical manifestations of the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) were evaluated in 90 patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) and 100 with APS </plain></SENT>
<SENT sid="1" pm="."><plain>Patients with APS were classified into <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo>, <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>, and pregnancy morbidity subgroups </plain></SENT>
<SENT sid="2" pm="."><plain>IgG, IgM, and IgA anticardiolipin (aCL), antiphosphatidylserine (aPS), anti-beta 2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (anti-B2GPI), and antiprothrombin (aPT) antibodies were determined by enzyme-linked immunosorbent assay </plain></SENT>
<SENT sid="3" pm="."><plain>Individually, anti-B2GPI and aPS antibodies had the strongest <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> for APS (86.4%-94.1%; P &lt; .001) in patients with SLE </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> for APS reached 100% when 2 or more antibodies were present </plain></SENT>
<SENT sid="5" pm="."><plain>Similarly, anti-B2GPI and aPS antibodies had a stronger <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> and association for <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> (87%-95%; P &lt; .001) compared with <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> (80%-92%; P = .01) </plain></SENT>
<SENT sid="6" pm="."><plain>Weak <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> and association with pregnancy morbidity were seen with <z:hpo ids='HP_0000001'>all</z:hpo> antibodies </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggest an important pathogenic role of anti-B2GPI antibodies in <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, anti-B2GPI and aPS antibodies seem to provide the best diagnostic value for the laboratory assessment of APS </plain></SENT>
</text></document>